1 |
Allo-hmscs |
- |
- |
- |
- |
211 2件: 211, 299 💬 |
2 |
Ambrisentan |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 7件: 51, 84, 85, 86, 88, 210, 211 💬 |
3 |
Autologous (self) mononuclear cells derived from umbilical cord blood |
- |
- |
- |
- |
211 1件: 211 💬 |
4 |
Autologous cell-based delivery |
- |
- |
- |
- |
211 1件: 211 💬 |
5 |
Autologous human placental cord blood mononuclear cells |
- |
- |
- |
- |
211 1件: 211 💬 |
6 |
Autologous umbilical cord blood |
- |
- |
- |
- |
211 2件: 211, 294 💬 |
7 |
Bosentan |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
8 |
C-kit+ cells |
- |
- |
- |
- |
211 1件: 211 💬 |
9 |
Curosurf |
- |
- |
- |
- |
211 1件: 211 💬 |
10 |
Erythropoetin |
- |
- |
- |
- |
211 1件: 211 💬 |
11 |
Longeveron mesenchymal stem cells |
- |
- |
- |
- |
211 1件: 211 💬 |
12 |
Maternal hyperoxygenation |
- |
- |
- |
- |
211 1件: 211 💬 |
13 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
14 |
Methylprednisolone sodium succinate |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 6件: 13, 46, 49, 50, 51, 211 💬 |
15 |
Metyyliprednisoloninatriumsuksinaatti |
- |
- |
- |
- |
211 1件: 211 💬 |
16 |
Mpc |
- |
- |
- |
- |
210 2件: 210, 211 💬 |
17 |
Nitrogen |
Nitrogen |
1件: D00083 D00083 💬 |
- |
- |
005 6件: 5 , 6 , 17, 171, 211, 299 💬 |
18 |
Normal saline |
- |
- |
- |
- |
006 16件: 6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬 |
19 |
Oxandrolone |
Oxandrolone |
1件: D00462 D00462 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
211 2件: 211, 285 💬 |
20 |
Procedure: stage ii surgical repair |
- |
- |
- |
- |
211 1件: 211 💬 |
21 |
Rexlemestrocel-l |
- |
- |
- |
- |
210 2件: 210, 211 💬 |
22 |
Sham |
- |
- |
- |
- |
211 1件: 211 💬 |
23 |
Sildenafil |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
24 |
Solu-medrol |
- |
- |
- |
- |
013 7件: 13, 49, 50, 51, 53, 97, 211 💬 |
25 |
Tracleer |
- |
- |
- |
- |
013 8件: 13, 51, 84, 85, 86, 88, 210, 211 💬 |
26 |
Vitamin c |
Ascorbic acid |
1件: D00018 D00018 💬 |
- |
- |
010 6件: 10, 192, 206, 210, 211, 212 💬 |